Loading provider…
Loading provider…
Anesthesiology Physician in Beachwood, OH
NPI: 1023261476Primary Practice Location
UNIVERSITY HOSPITALS AHUJA MEDICAL CENTER
3999 Richmond Rd, Beachwood, OH
Primary Employer
University Hospitals Medical Group Inc
uhhospitals.org
HQ Phone
Get MD Melinda's Phone Numberphone_androidMobile
Get MD Melinda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License

American Board of Anesthesiology
Anesthesiology

American Board of Anesthesiology
Pain Medicine
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99204New patient office or other outpatient visit, 45-59 minutes | 191 | 191 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 146 | 179 |
| 3 | 64483Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 145 | 188 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 98 | 117 |
| 5 | 62323Injection of substance into spinal canal of lower back or sacrum using imaging guidance | 79 | 91 |
Authors: Hayek, Salim M, Lawrence, Melinda M
Journal: JAMA Oncol
Authors: De Andres, Jose, Hayek, Salim, Perruchoud, Christophe, Lawrence, Melinda M, Reina, Miguel Angel, De Andres-Serrano, Carmen, Rubio-Haro, Ruben, Hunt, Mathew, Yaksh, Tony L
Journal: Front Pain Res (Lausanne)
Publication Date: 2023-04-11
Lead Sponsor: University Hospitals Cleveland Medical Center
Intervention / Treatment: DRUG: Placebo, DRUG: Fentanyl, DRUG: Bupivacaine, OTHER: Continuous intrathecal prognostic infusion test, DEVICE: Intrathecal Drug Delivery System (IDDS)
Lead Sponsor: University Hospitals Cleveland Medical Center
Intervention / Treatment: DRUG: MSC Treatment group 1 (low dose), DRUG: MSC Treatment group 2 (high dose), OTHER: Healthy Control (no treatment)
Journal: Pain Manag
Publication Date: 2023-01-24